Skip to main content

Table 1 Patient’s characteristics

From: The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt

Characteristics  
Age (years), mean ± SD 55.2 ± 9.8
Age, N (%)
 < 55 32 (45.7)
 ≥ 55 38 (54.3)
Gender, N (%)
 Female 19 (27.1)
 Male 51 (72.9)
Smoking status, N (%)
 Never-smoker 27 (38.6)
 Current/ex-smoker 43 (61.4)
Grade, N (%)
 1–2 51 (72.9)
 3 19 (27.1)
Stage, N (%)
 I 12 (17.1)
 II 15 (21.4)
 III 12 (17.1)
 IV 31 (44.3)
Tumor size (cm), mean ± SD 5.4 ± 2.78
Tumor size (cm), N (%)
 < 4 25 (35.7)
 ≥ 4 45 (64.3)
Laterality, N (%)
 Left 36 (51.4)
 Right 34 (48.6)
LN metastasis, N (%)
 No 34 (48.6)
 Yes 36 (51.4)
EGFR mutation, N (%)
 Wild type 40 (57.1)
 Mutant 21 (30.0)
 Unknown 9 (12.9)
  1. LN lymph node, EGFR epidermal growth factor receptor